$THM
INTERNATIONAL TOWER HILL MINES LTD

2023 Q1 Form 10-K Financial Statement

#000141057823000217 Filed on March 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $368.2K $521.6K $2.292M
YoY Change -13.51% 6.83% -3.72%
% of Gross Profit
Research & Development $145.9K $277.6K $1.138M
YoY Change -28.16% -41.4% -67.64%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $518.3K $793.3K $3.446M
YoY Change -18.17% -17.99% -41.75%
Operating Profit
YoY Change
Interest Expense $14.79K -$61.37K $354.0K
YoY Change -115.87% 23.75% -533.97%
% of Operating Profit
Other Income/Expense, Net $14.79K $22.46K $404.3K
YoY Change -118.37% 1470.63% -723.62%
Pretax Income -$503.5K -$832.2K -$3.042M
YoY Change -29.47% -18.05% -49.14%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$503.5K -$832.2K -$3.042M
YoY Change -29.47% -18.05% -49.14%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.02
Diluted Earnings Per Share $0.00 $0.00 -$0.02
COMMON SHARES
Basic Shares Outstanding 195.3M 195.3M 195.2M
Diluted Shares Outstanding 195.3M 195.2M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.231M $4.847M $4.847M
YoY Change -41.64% -37.7% -37.7%
Cash & Equivalents $4.231M $4.847M $4.847M
Short-Term Investments
Other Short-Term Assets $170.7K $152.6K $152.6K
YoY Change 3.69% 7.69% 7.69%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.402M $5.000M $5.000M
YoY Change -40.63% -36.89% -36.89%
LONG-TERM ASSETS
Property, Plant & Equipment $7.465K $7.465K $55.38M
YoY Change 0.0% 0.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $55.38M $55.38M $55.38M
YoY Change 0.0% 0.0% 0.0%
TOTAL ASSETS
Total Short-Term Assets $4.402M $5.000M $5.000M
Total Long-Term Assets $55.38M $55.38M $55.38M
Total Assets $59.78M $60.38M $60.38M
YoY Change -4.8% -4.62% -4.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $52.74K $53.54K $53.54K
YoY Change -72.61% -79.38% -79.38%
Accrued Expenses $120.3K $234.8K $234.9K
YoY Change -14.91% -26.66% -26.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $173.0K $288.4K $288.4K
YoY Change -48.18% -50.27% -50.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $173.0K $288.4K $288.4K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $173.0K $288.4K $288.4K
YoY Change -48.18% -50.27% -50.27%
SHAREHOLDERS EQUITY
Retained Earnings -$266.7M -$266.2M
YoY Change 1.07% 1.16%
Common Stock $324.8M $324.8M
YoY Change 0.14% 0.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $59.61M $60.09M $60.09M
YoY Change
Total Liabilities & Shareholders Equity $59.78M $60.38M $60.38M
YoY Change -4.8% -4.62% -4.62%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$503.5K -$832.2K -$3.042M
YoY Change -29.47% -18.05% -49.14%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change -100.0%
Cash From Operating Activities -$616.7K -$688.1K -$2.897M
YoY Change -35.3% -54.26% -45.72%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $290.3K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 290.3K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -616.7K -688.1K -2.897M
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000 0.000 290.3K
Net Change In Cash -616.1K -688.1K -2.933M
YoY Change 16.06% -54.26% -44.33%
FREE CASH FLOW
Cash From Operating Activities -$616.7K -$688.1K -$2.897M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
195221951
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
194908184
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
195313184
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
194908184
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
195313184
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
194908184
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001134115
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2021 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2021 thm Reallocation From Contributed Surplus
ReallocationFromContributedSurplus
0
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-33638
CY2022 dei Entity Registrant Name
EntityRegistrantName
INTERNATIONAL TOWER HILL MINES LTD.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
CY2022 dei Entity Address Country
EntityAddressCountry
CA
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0668474
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2710-200 Granville Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2022 dei Entity Address Country
EntityAddressCountry
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 1S4
CY2022 dei City Area Code
CityAreaCode
604
CY2022 dei Local Phone Number
LocalPhoneNumber
683-6332
CY2022 dei Security12b Title
Security12bTitle
Common Shares, no par value
CY2022 dei Trading Symbol
TradingSymbol
THM
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
67400000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
195313184
CY2022 dei Auditor Name
AuditorName
DAVIDSON & COMPANY LLP
CY2022 dei Auditor Location
AuditorLocation
Vancouver, Canada
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4847429
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7780671
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
152572
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
141680
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5000001
CY2021Q4 us-gaap Assets Current
AssetsCurrent
7922351
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7465
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7465
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
55375124
CY2021Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
55375124
CY2022Q4 us-gaap Assets
Assets
60382590
CY2021Q4 us-gaap Assets
Assets
63304940
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
53539
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
259648
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
234846
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
320233
CY2022Q4 us-gaap Liabilities
Liabilities
288385
CY2021Q4 us-gaap Liabilities
Liabilities
579881
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195313184
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
194908184
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
288484901
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
288032132
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36275917
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
35989922
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1500196
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1828121
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-266166809
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-263125116
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
60094205
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
62725059
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60382590
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63304940
CY2022 thm Consulting Fees
ConsultingFees
551163
CY2021 thm Consulting Fees
ConsultingFees
612387
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
367
CY2022 us-gaap General Insurance Expense
GeneralInsuranceExpense
202893
CY2021 us-gaap General Insurance Expense
GeneralInsuranceExpense
179659
CY2022 thm Investor Relations Expenses
InvestorRelationsExpenses
65591
CY2021 thm Investor Relations Expenses
InvestorRelationsExpenses
77256
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1138134
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3517540
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28529
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33292
CY2022 us-gaap Other Expenses
OtherExpenses
16130
CY2021 us-gaap Other Expenses
OtherExpenses
17181
CY2022 us-gaap Professional Fees
ProfessionalFees
226439
CY2021 us-gaap Professional Fees
ProfessionalFees
210594
CY2022 thm Regulatory Expenses
RegulatoryExpenses
137947
CY2021 thm Regulatory Expenses
RegulatoryExpenses
178264
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
135200
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
135372
CY2022 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
29935
CY2021 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
18464
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
914078
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
935073
CY2022 us-gaap Operating Expenses
OperatingExpenses
3446039
CY2021 us-gaap Operating Expenses
OperatingExpenses
5915449
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
348207
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-101818
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
5739
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
20260
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
50400
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16719
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
404346
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-64839
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-3041693
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-5980288
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-327925
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
68893
CY2022 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-327925
CY2021 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
68893
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3369618
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5911395
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
195221951
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
194908184
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
68101337
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
167267
CY2021 thm Adjustments To Additional Paid In Capital Share Based Compensation Deferred Share Unit Plan
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationDeferredShareUnitPlan
367850
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
68893
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-5980288
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
62725059
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
135451
CY2022 thm Adjustments To Additional Paid In Capital Share Based Compensation Deferred Share Unit Plan
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationDeferredShareUnitPlan
313023
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-327925
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
290290
CY2022 thm Reallocation From Contributed Surplus
ReallocationFromContributedSurplus
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-3041693
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
60094205
CY2022 us-gaap Profit Loss
ProfitLoss
-3041693
CY2021 us-gaap Profit Loss
ProfitLoss
-5980288
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
367
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
135451
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
167267
CY2022 thm Deferred Stock Or Unit Expense
DeferredStockOrUnitExpense
313023
CY2021 thm Deferred Stock Or Unit Expense
DeferredStockOrUnitExpense
367850
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5794
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18770
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
22076
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1555
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-287457
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
86964
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2896958
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5337515
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
290290
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
290290
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-326574
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68893
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2933242
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5268622
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7780671
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13049293
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4847429
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7780671
CY2022 thm Reallocation From Contributed Surplus From Stock Options
ReallocationFromContributedSurplusFromStockOptions
162479
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">1.           GENERAL INFORMATION, NATURE OF OPERATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">International Tower Hill Mines Ltd. (“ITH” or the “Company”) is incorporated under the laws of British Columbia, Canada. The Company’s head office address is 2710-200 Granville Street, Vancouver, British Columbia, Canada.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">International Tower Hill Mines Ltd. consists of ITH and its wholly owned subsidiaries Tower Hill Mines, Inc. (“TH Alaska”) (an Alaska corporation), Tower Hill Mines (US) LLC (“TH US”) (a Colorado limited liability company), and Livengood Placers, Inc. (“LPI”) (a Nevada corporation). The Company is in the business of acquiring, exploring and evaluating mineral properties, and either joint venturing or developing these properties further or disposing of them when the evaluation is completed. At December 31, 2022, the Company was in the exploration stage and controls a 100% interest in its Livengood Gold Project in Alaska, U.S.A.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">These consolidated financial statements have been prepared on a going-concern basis, which presumes the realization of assets and discharge of liabilities in the normal course of business for the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">The Company will require significant additional financing to continue its operations in connection with advancing activities at the Livengood Gold Project and for the development of any mine that may be determined to be built at the Livengood Gold Project. There is no assurance that the Company will be able to obtain the additional financing required on acceptable terms, if at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">In addition, any significant delays in the issuance of required permits for the ongoing work at the Livengood Gold Project, or unexpected results in connection with the ongoing work, could result in the Company being required to raise additional funds to advance permitting efforts. The Company’s review of its financing options includes pursuing a future strategic alliance to assist in further development, permitting and future construction costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">Despite the Company’s success to date in raising significant equity financing to fund its operations, there is significant uncertainty that the Company will be able to secure any additional financing in the current or future equity markets. The amount of funds to be raised and the terms of any proposed equity financing that may be undertaken will be negotiated by management as opportunities to raise funds arise. Specific plans related to the use of proceeds will be devised once financing has been completed and management knows what funds will be available for these purposes. Due to this uncertainty, if the Company is unable to secure additional financing, it may be required to reduce all discretionary activities at the Project to preserve its working capital to fund anticipated non-discretionary expenditures beyond the 2023 fiscal year. As at March 7, 2023, management believes that the Company has sufficient financial resources to maintain its operations for the next twelve months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 36pt;">The COVID-19 pandemic of three years has resulted in supply chain disruptions, record high inflation and rising interest rates which all have impeded adversely the global economy and tightened the financial markets. It is indeterminable when inflation will be back to a normal level and the economy will recover. These have created uncertainties to whether financing would be available to the Company if the need for funding was to arise.</p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Significant judgments, estimates and assumptions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 35.45pt;">The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 35.45pt;">The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are not limited to the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Significant judgments</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><span style="font-family:'Times New Roman';">●</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">the determination of functional currencies;</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><span style="font-family:'Times New Roman';">●</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">quantitative and qualitative factors used in the assessment of impairment of the Company’s mineral property; and</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:54pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><span style="font-family:'Times New Roman';">●</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">the analysis of resource calculations, drill results, labwork, etc. which can impact the Company’s assessment of impairment, and provisions, if any, for environmental rehabilitation and restoration.</p></td></tr></table>
CY2021 thm Geological And Geophysical Costs
GeologicalAndGeophysicalCosts
2121323
CY2022 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
647412
CY2021 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
709922
CY2022 us-gaap Legal Fees
LegalFees
85593
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2020Q4 thm Capitalized Costs Mineral Properties
CapitalizedCostsMineralProperties
55375124
CY2021 us-gaap Acquisition Costs
AcquisitionCosts
0
CY2021Q4 thm Capitalized Costs Mineral Properties
CapitalizedCostsMineralProperties
55375124
CY2022 us-gaap Acquisition Costs
AcquisitionCosts
0
CY2022Q4 thm Capitalized Costs Mineral Properties
CapitalizedCostsMineralProperties
55375124
CY2022 thm Aircraft Services Costs
AircraftServicesCosts
9000
CY2021 thm Aircraft Services Costs
AircraftServicesCosts
8400
CY2022 thm Environmental Costs
EnvironmentalCosts
191876
CY2021 thm Environmental Costs
EnvironmentalCosts
185330
CY2022 thm Equipment Rental
EquipmentRental
67507
CY2021 thm Equipment Rental
EquipmentRental
61409
CY2022 thm Mining Activities Field Costs
MiningActivitiesFieldCosts
89493
CY2021 thm Mining Activities Field Costs
MiningActivitiesFieldCosts
327075
CY2022 thm Geological And Geophysical Costs
GeologicalAndGeophysicalCosts
49202
CY2021 us-gaap Legal Fees
LegalFees
90542
CY2022 thm Transportation And Traveling Cost
TransportationAndTravelingCost
-1949
CY2021 thm Transportation And Traveling Cost
TransportationAndTravelingCost
13539
CY2022 us-gaap Costs Incurred Exploration Costs
CostsIncurredExplorationCosts
1138134
CY2021 us-gaap Costs Incurred Exploration Costs
CostsIncurredExplorationCosts
3517540
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
104198
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
202982
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
130648
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
117251
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
234846
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
320233
CY2022Q4 thm Accrued General Corporate Cost Current
AccruedGeneralCorporateCostCurrent
46974
CY2022Q4 thm Accrued Project Cost Current
AccruedProjectCostCurrent
57224
CY2021Q4 thm Accrued General Corporate Cost Current
AccruedGeneralCorporateCostCurrent
34912
CY2021Q4 thm Accrued Project Cost Current
AccruedProjectCostCurrent
168070
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3041693
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5980288
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2700
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2700
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-821000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1614678
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1038000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
3029412
CY2022 thm Income Tax Reconciliation Nondeductible Expense Permanent Difference
IncomeTaxReconciliationNondeductibleExpensePermanentDifference
120000
CY2021 thm Income Tax Reconciliation Nondeductible Expense Permanent Difference
IncomeTaxReconciliationNondeductibleExpensePermanentDifference
123866
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
279000
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-7996
CY2022 thm Income Tax Reconciliation Nondeductible Expense Temporary Difference
IncomeTaxReconciliationNondeductibleExpenseTemporaryDifference
616000
CY2021 thm Income Tax Reconciliation Nondeductible Expense Temporary Difference
IncomeTaxReconciliationNondeductibleExpenseTemporaryDifference
1530604
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q4 thm Deferred Tax Assets Exploration And Evaluation Assets
DeferredTaxAssetsExplorationAndEvaluationAssets
16711000
CY2021Q4 thm Deferred Tax Assets Exploration And Evaluation Assets
DeferredTaxAssetsExplorationAndEvaluationAssets
16711128
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
7000
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
10464
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
51000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
83928
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
53955000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
55506071
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
70724000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
72311591
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
70724000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
72311591
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
33301000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195313184
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
194908184
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M6D
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2287049
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2047049
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2947049
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2702049
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
170000
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.76
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
240000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.98
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
165000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.87
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
245000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.91
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
240000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.60
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
245000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.78
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
240000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.73
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
67694
CY2022Q4 thm Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPercentage
0.0117
CY2022 thm Share Based Compensation Arrangement By Share Based Payment Towards Equity Instruments Other Than Options Grants In Period Aggregate Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentTowardsEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue
83000
CY2021 thm Share Based Compensation Arrangement By Share Based Payment Towards Equity Instruments Other Than Options Grants In Period Aggregate Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentTowardsEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue
83000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
448474
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
535117
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0264
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0099
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7675
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8122
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.92
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.31
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
55375124
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7465
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5000001
CY2022Q4 us-gaap Assets
Assets
60382590
CY2021Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
55375124
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7465
CY2021Q4 us-gaap Assets Current
AssetsCurrent
7922351
CY2021Q4 us-gaap Assets
Assets
63304940
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-3041693
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-5980288
CY2022Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
741793
CY2022Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
747488
CY2022Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
753254
CY2022Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
759092
CY2022Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
765003
CY2022Q4 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
770988
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
4537618
CY2022 dei Auditor Firm
AuditorFirmId
731

Files In Submission

Name View Source Status
thm-20221231x10k_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
0001410578-23-000217-index-headers.html Edgar Link pending
0001410578-23-000217-index.html Edgar Link pending
0001410578-23-000217.txt Edgar Link pending
0001410578-23-000217-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thm-20221231.xsd Edgar Link pending
thm-20221231x10k.htm Edgar Link pending
thm-20221231x10k001.jpg Edgar Link pending
thm-20221231x10k002.jpg Edgar Link pending
thm-20221231x10k003.jpg Edgar Link pending
thm-20221231x10k006.jpg Edgar Link pending
thm-20221231x10k007.jpg Edgar Link pending
thm-20221231xex23d1.htm Edgar Link pending
thm-20221231xex23d1001.jpg Edgar Link pending
thm-20221231xex23d1002.jpg Edgar Link pending
thm-20221231xex23d2.htm Edgar Link pending
thm-20221231xex23d3.htm Edgar Link pending
thm-20221231xex23d4.htm Edgar Link pending
thm-20221231xex23d5.htm Edgar Link pending
thm-20221231xex31d1.htm Edgar Link pending
thm-20221231xex31d2.htm Edgar Link pending
thm-20221231xex32d1.htm Edgar Link pending
thm-20221231xex32d2.htm Edgar Link pending
thm-20221231xex96d1.htm Edgar Link pending
thm-20221231xex96d1001.jpg Edgar Link pending
thm-20221231xex96d1002.jpg Edgar Link pending
thm-20221231xex96d1003.jpg Edgar Link pending
thm-20221231xex96d1010.jpg Edgar Link pending
thm-20221231xex96d1011.jpg Edgar Link pending
thm-20221231xex96d1014.jpg Edgar Link pending
thm-20221231xex96d1017.jpg Edgar Link pending
thm-20221231xex96d1018.jpg Edgar Link pending
thm-20221231xex96d1019.jpg Edgar Link pending
thm-20221231xex96d1024.jpg Edgar Link pending
thm-20221231xex96d1032.jpg Edgar Link pending
thm-20221231xex96d1033.jpg Edgar Link pending
thm-20221231xex96d1034.jpg Edgar Link pending
thm-20221231xex96d1035.jpg Edgar Link pending
thm-20221231xex96d1036.jpg Edgar Link pending
thm-20221231xex96d1037.jpg Edgar Link pending
thm-20221231xex96d1038.jpg Edgar Link pending
thm-20221231xex96d1039.jpg Edgar Link pending
thm-20221231xex96d1042.jpg Edgar Link pending
thm-20221231xex96d1043.jpg Edgar Link pending
thm-20221231xex96d1044.jpg Edgar Link pending
thm-20221231xex96d1045.jpg Edgar Link pending
thm-20221231xex96d1050.jpg Edgar Link pending
thm-20221231xex96d1051.jpg Edgar Link pending
thm-20221231xex96d1052.jpg Edgar Link pending
thm-20221231xex96d1053.jpg Edgar Link pending
thm-20221231xex96d1054.jpg Edgar Link pending
thm-20221231xex96d1063.jpg Edgar Link pending
thm-20221231xex96d1064.jpg Edgar Link pending
thm-20221231xex96d1065.jpg Edgar Link pending
thm-20221231xex96d1066.jpg Edgar Link pending
thm-20221231xex96d1067.jpg Edgar Link pending
thm-20221231xex96d1068.jpg Edgar Link pending
thm-20221231xex96d1069.jpg Edgar Link pending
thm-20221231xex96d1070.jpg Edgar Link pending
thm-20221231xex96d1071.jpg Edgar Link pending
thm-20221231xex96d1072.jpg Edgar Link pending
thm-20221231xex96d1073.jpg Edgar Link pending
thm-20221231xex96d1074.jpg Edgar Link pending
thm-20221231xex96d1075.jpg Edgar Link pending
thm-20221231xex96d1076.jpg Edgar Link pending
thm-20221231xex96d1077.jpg Edgar Link pending
thm-20221231xex96d1078.jpg Edgar Link pending
thm-20221231xex96d1079.jpg Edgar Link pending
thm-20221231xex96d1080.jpg Edgar Link pending
thm-20221231xex96d1081.jpg Edgar Link pending
thm-20221231xex96d1082.jpg Edgar Link pending
thm-20221231xex96d1083.jpg Edgar Link pending
thm-20221231xex96d1088.jpg Edgar Link pending
thm-20221231xex96d1089.jpg Edgar Link pending
thm-20221231xex96d1090.jpg Edgar Link pending
thm-20221231xex96d1091.jpg Edgar Link pending
thm-20221231xex96d1092.jpg Edgar Link pending
thm-20221231xex96d1093.jpg Edgar Link pending
thm-20221231xex96d1094.jpg Edgar Link pending
thm-20221231xex96d1095.jpg Edgar Link pending
thm-20221231xex96d1096.jpg Edgar Link pending
thm-20221231xex96d1097.jpg Edgar Link pending
thm-20221231xex96d1098.jpg Edgar Link pending
thm-20221231xex96d1099.jpg Edgar Link pending
thm-20221231xex96d1100.jpg Edgar Link pending
thm-20221231xex96d1101.jpg Edgar Link pending
thm-20221231xex96d1102.jpg Edgar Link pending
thm-20221231xex96d1107.jpg Edgar Link pending
thm-20221231xex96d1108.jpg Edgar Link pending
thm-20221231xex96d1109.jpg Edgar Link pending
thm-20221231xex96d1110.jpg Edgar Link pending
thm-20221231xex96d1111.jpg Edgar Link pending
thm-20221231xex96d1112.jpg Edgar Link pending
thm-20221231xex96d1113.jpg Edgar Link pending
thm-20221231xex96d1114.jpg Edgar Link pending
thm-20221231xex96d1115.jpg Edgar Link pending
thm-20221231xex96d1116.jpg Edgar Link pending
thm-20221231xex96d1117.jpg Edgar Link pending
thm-20221231xex96d1118.jpg Edgar Link pending
thm-20221231xex96d1119.jpg Edgar Link pending
thm-20221231xex96d1120.jpg Edgar Link pending
thm-20221231xex96d1121.jpg Edgar Link pending
thm-20221231xex96d1122.jpg Edgar Link pending
thm-20221231xex96d1123.jpg Edgar Link pending
thm-20221231xex96d1124.jpg Edgar Link pending
thm-20221231xex96d1125.jpg Edgar Link pending
thm-20221231xex96d1126.jpg Edgar Link pending
thm-20221231xex96d1127.jpg Edgar Link pending
thm-20221231xex96d1128.jpg Edgar Link pending
thm-20221231xex96d1129.jpg Edgar Link pending
thm-20221231xex96d1130.jpg Edgar Link pending
thm-20221231xex96d1137.jpg Edgar Link pending
thm-20221231xex96d1138.jpg Edgar Link pending
thm-20221231xex96d1141.jpg Edgar Link pending
thm-20221231xex96d1142.jpg Edgar Link pending
thm-20221231xex96d1143.jpg Edgar Link pending
thm-20221231xex96d1144.jpg Edgar Link pending
thm-20221231xex96d1145.jpg Edgar Link pending
thm-20221231xex96d1146.jpg Edgar Link pending
thm-20221231xex96d1147.jpg Edgar Link pending
thm-20221231xex96d1148.jpg Edgar Link pending
thm-20221231xex96d1149.jpg Edgar Link pending
thm-20221231xex96d1152.jpg Edgar Link pending
thm-20221231xex96d1153.jpg Edgar Link pending
thm-20221231xex96d1154.jpg Edgar Link pending
thm-20221231xex96d1155.jpg Edgar Link pending
thm-20221231xex96d1156.jpg Edgar Link pending
thm-20221231xex96d1157.jpg Edgar Link pending
thm-20221231xex96d1158.jpg Edgar Link pending
thm-20221231xex96d1159.jpg Edgar Link pending
thm-20221231xex96d1160.jpg Edgar Link pending
thm-20221231xex96d1161.jpg Edgar Link pending
thm-20221231xex96d1164.jpg Edgar Link pending
thm-20221231xex96d1165.jpg Edgar Link pending
thm-20221231xex96d1166.jpg Edgar Link pending
thm-20221231xex96d1171.jpg Edgar Link pending
thm-20221231xex96d1174.jpg Edgar Link pending
thm-20221231xex96d1175.jpg Edgar Link pending
thm-20221231xex96d1180.jpg Edgar Link pending
thm-20221231xex96d1183.jpg Edgar Link pending
thm-20221231xex96d1188.jpg Edgar Link pending
thm-20221231xex96d1189.jpg Edgar Link pending
thm-20221231xex96d1190.jpg Edgar Link pending
thm-20221231xex96d1191.jpg Edgar Link pending
thm-20221231xex96d1192.jpg Edgar Link pending
thm-20221231xex96d1193.jpg Edgar Link pending
thm-20221231xex96d1196.jpg Edgar Link pending
thm-20221231xex96d1197.jpg Edgar Link pending
thm-20221231xex96d1198.jpg Edgar Link pending
thm-20221231xex96d1199.jpg Edgar Link pending
thm-20221231xex96d1200.jpg Edgar Link pending
thm-20221231xex96d1201.jpg Edgar Link pending
thm-20221231xex96d1202.jpg Edgar Link pending
thm-20221231xex96d1208.jpg Edgar Link pending
thm-20221231xex96d1209.jpg Edgar Link pending
thm-20221231xex96d1210.jpg Edgar Link pending
thm-20221231xex96d1211.jpg Edgar Link pending
thm-20221231xex96d1212.jpg Edgar Link pending
thm-20221231xex96d1213.jpg Edgar Link pending
thm-20221231xex96d1214.jpg Edgar Link pending
thm-20221231xex96d1215.jpg Edgar Link pending
thm-20221231xex96d1216.jpg Edgar Link pending
thm-20221231xex96d1219.jpg Edgar Link pending
thm-20221231xex96d1222.jpg Edgar Link pending
thm-20221231xex96d1227.jpg Edgar Link pending
thm-20221231xex96d1232.jpg Edgar Link pending
thm-20221231xex96d1235.jpg Edgar Link pending
thm-20221231xex96d1240.jpg Edgar Link pending
thm-20221231xex96d1241.jpg Edgar Link pending
thm-20221231xex96d1244.jpg Edgar Link pending
thm-20221231xex96d1249.jpg Edgar Link pending
thm-20221231xex96d1252.jpg Edgar Link pending
thm-20221231xex96d1253.jpg Edgar Link pending
thm-20221231xex96d1260.jpg Edgar Link pending
thm-20221231xex96d1263.jpg Edgar Link pending
thm-20221231xex96d1274.jpg Edgar Link pending
thm-20221231xex96d1275.jpg Edgar Link pending
thm-20221231xex96d1278.jpg Edgar Link pending
thm-20221231_cal.xml Edgar Link unprocessable
thm-20221231_def.xml Edgar Link unprocessable
thm-20221231_lab.xml Edgar Link unprocessable
thm-20221231_pre.xml Edgar Link unprocessable